Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer
Clicks: 351
ID: 117335
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.0
/100
20 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Adjuvant chemotherapy should be recommended, and additional treatment for recurrence is effective even among elderly who have not received adjuvant chemotherapy.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
sh2019anticancerprognostic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Shin SH;Park Y;Hwang DW;Song KB;Lee JH;Kwon J;Yoo C;Alshammary S;Kim SC;; |
| Journal | Anticancer research |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
local
chemotherapy
humans
pubmed abstract
nih
national institutes of health
national library of medicine
prognosis
treatment outcome
female
male
age factors
aged
middle aged
80 and over
Retrospective Studies
Survival Analysis
sang hyun shin
carcinoma
neoplasm recurrence
disease-free survival
pancreatic neoplasms / surgery*
song cheol kim
adjuvant
adenocarcinoma / surgery*
pmid:30711988
doi:10.21873/anticanres.13206
yejong park
adenocarcinoma / drug therapy*
anastomosis
surgical
pancreatic ductal / drug therapy*
pancreatic ductal / surgery*
pancreatic neoplasms / diagnosis
pancreatic neoplasms / drug therapy*
pancreaticoduodenectomy
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.